查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511857

華盛頓州合法大麻市場規模、佔有率和趨勢分析報告：按來源、衍生物、按最終用途、細分市場預測，2024-2030 年

Washington Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By End-use (Industrial Use, Medical Use), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

華盛頓州合法大麻市場成長與趨勢

Grand View Research, Inc.的最新報告顯示，到2030年，華盛頓州合法大麻市場規模預計將達到33.4億美元，2024年至2030年的複合年成長率為14.4%。消費者可支配收入增加、藥用大麻合法化、消費者對大麻健康益處的認知不斷增強、製藥業對大麻的需求增加以及美國農業法案的核准等因素預計將推動市場成長。

大麻廣泛用於治療各種健康狀況，包括癌症、精神疾病、疼痛和噁心，以及用於娛樂目的。在預測期內，癌症發生率的增加預計將極大促進醫用大麻的接受度不斷提高。例如，根據美國癌症協會2023年1月發表的報導，預計2023年美國將有609,820人死於癌症，並且將有1,958,310人新診斷出患有癌症。在美國，兩種CBD藥物（大麻龍和屈大麻酚）已被FDA核准用於治療化療引起的噁心和嘔吐。

此外，大麻認證計劃的數量不斷增加以及人們對大麻治療功效的認知不斷提高正在推動市場成長。例如，華盛頓州塔科馬社區學院提供為期九週的線上認證計劃，幫助學生了解大麻供應鏈並培養在大麻種植環境中蓬勃發展所需的技能。此外，對各種含有 CBD 的產品的需求不斷成長，包括飲料、大麻油、美容產品、膠囊和軟糖。讓 CBD 進入體內的方法有很多，包括電子煙、吸煙和局部使用。大麻已在華盛頓州合法化，CBD 正用於個人保健產品和藥物的開發。大麻產品的合法化為各行業擴大產品範圍創造了巨大的擴張機會。

此外，大麻種植的新技術和改進也在不斷開發。隨著對技術先進的大麻生產的需求不斷增加，這些增強的技術預計將幫助種植者最佳化資源並進一步推動市場成長。

華盛頓合法大麻市場報告亮點

  • 從來源來看，由於人們對大麻用於醫療目的的認知提高以及對其治療效果的研究增加，大麻產業在 2023 年的銷售額中佔據最大佔有率。
  • 從衍生性商品來看，由於對含有 CBD 的食品、化妝品和藥品的需求增加，CBD 產業在 2023 年佔據了最大的銷售佔有率。
  • 按最終用途分類，由於吸煙和食用大麻的需求不斷成長，娛樂用途細分市場在 2023 年佔據最大的市場佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章華盛頓州合法大麻市場的變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 案例研究分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析
  • 監管狀況

第 4 章 2018-2030 年華盛頓州合法大麻市場細分分析（按來源）

  • 定義和範圍
  • 源細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • 大麻
    • 2018-2030 年市場估計與預測
    • 大麻CBD
    • 工業大麻
  • 大麻
    • 2018-2030 年市場估計與預測
    • 花
    • 油和酊劑

第 5 章. 華盛頓州合法大麻市場細分分析（按衍生物），2018-2030

  • 定義和範圍
  • 衍生物細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • CBD
    • 2018-2030 年市場估計與預測
  • THC
    • 2018-2030 年市場估計與預測
  • 其他
    • 2018-2030 年市場估計與預測

第 6 章：2018-2030 年華盛頓州合法大麻市場細分分析（按最終用途）

  • 定義和範圍
  • 最終用途細分儀表板
  • 2018-2030年市場規模、預測及趨勢分析
  • 工業用途
    • 2018-2030 年市場估計與預測
  • 醫療用途
    • 2018-2030 年市場估計與預測
    • 慢性疼痛
    • 憂鬱症和焦慮
    • 關節炎
    • 創傷後壓力症候群（PTSD）
    • 癌症
    • 偏頭痛
    • 癲癇
    • 阿茲海默症
    • 多發性硬化症
    • 肌萎縮側索硬化症
    • 妥瑞症
    • 糖尿病
    • 帕金森氏症
    • 青光眼
    • 其他
  • 休閒用途
    • 2018-2030 年市場估計與預測

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司市場分析
  • 公司簡介
    • NORTHWEST CANNABIS SOLUTIONS
    • The Hollingsworth Cannabis Company, LLC
    • Alkaloid Cannabis Company
    • Herbs House
    • Nirvana Cannabis
    • Edgemont Group（Leafwerx）
    • OLYMPIA WEED COMPANY
    • Canna West Seattle
    • Grow Op Farms（Phat Panda）
    • Forbidden Farms, LLC
Product Code: GVR-4-68040-306-0

Washington Legal Cannabis Market Growth & Trends:

The Washington legal cannabis market size is expected to reach USD 3.34 billion by 2030, registering a CAGR of 14.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as growing consumer disposable income, legalization of medicinal cannabis, growing consumer awareness of the health benefits of cannabis, increasing demand for cannabis from the pharmaceutical industry, and the approval of the U.S. Farm Bill are expected to boost the market growth.

Cannabis is widely utilized for managing a range of health conditions, including cancer, mental health issues, pain, and nausea, and for recreational purposes. The growing incidence of cancer is anticipated to significantly contribute to the growing acceptance of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were projected to occur in the U.S. in 2023. In the U.S., two CBD drugs (nabilone and dronabinol) are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy.

In addition, the rise in cannabis certification programs and growing awareness among people regarding the therapeutic benefits of cannabis boosts market growth. For instance, Washington-based Tacoma Community College offers a 9-week online certificate program that gives an understanding of the cannabis supply chain and the skills needed to excel in the cannabis cultivation environment. Moreover, there is a growing demand for various CBD-infused products, such as beverages, cannabis oil, beauty products, capsules, gummies, etc. Various methods, such as vaping, smoking, or topical application, can introduce CBD into the body. In Washington, cannabis is legal, and CBD is employed to develop personal care products and medicinal products. The legalization of cannabis-based products created significant expansion opportunities for various industries to broaden their range of products.

Furthermore, new technologies and improvements are continually being developed for cannabis cultivation. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, further driving the market's growth.

Washington Legal Cannabis Market Report Highlights:

  • By source, the marijuana segment accounted for the largest revenue share in 2023, owing to the recognition of cannabis for medical purposes and growing research studies for its therapeutic benefits
  • By derivatives, the CBD segment dominated the market with the largest revenue share in 2023, due to rise in demand for CBD-infused food, cosmetics, and medication
  • By end use, the recreational use segment held the largest market share in 2023 due to the growing demand for cannabis for smoking and consuming it in the form of foods & beverage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Derivatives
    • 1.2.3. End-use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Source outlook
    • 2.2.2. Derivatives outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Washington Legal Cannabis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Case Study Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Landscape

Chapter 4. Washington Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Source Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4. Hemp
    • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hemp CBD
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Industrial Hemp
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Marijuana
    • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Flower
      • 4.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Oil and Tinctures
      • 4.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Washington Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Derivatives Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. CBD
    • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. THC
    • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Washington Legal Cannabis Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End-use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Industrial Use
    • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Medical Use
    • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Chronic Pain
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Depression and Anxiety
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Arthritis
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Post-traumatic Stress Disorder (PTSD)
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Cancer
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Migraines
      • 6.5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Epilepsy
      • 6.5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Alzheimer's
      • 6.5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Multiple Sclerosis
      • 6.5.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.11. Amyotrophic Lateral Sclerosis
      • 6.5.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.12. Tourette's
      • 6.5.12.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.13. Diabetes
      • 6.5.13.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.14. Parkinson's
      • 6.5.14.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.15. Glaucoma
      • 6.5.15.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.16. Others
      • 6.5.16.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Recreational Use
    • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Position Analysis
  • 7.4. Company Profiles
    • 7.4.1. NORTHWEST CANNABIS SOLUTIONS
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Service Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. The Hollingsworth Cannabis Company, LLC
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Service Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Alkaloid Cannabis Company
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Service Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Herbs House
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Service Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Nirvana Cannabis
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Service Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Edgemont Group (Leafwerx)
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Service Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. OLYMPIA WEED COMPANY
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Service Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Canna West Seattle
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Service Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Grow Op Farms (Phat Panda)
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Service Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Forbidden Farms, LLC
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Service Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Washington legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 4 Washington legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 5 Washington legal cannabis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market research approaches
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. cannabis market: market outlook
  • Fig. 9 U.S. cannabis competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Washington legal cannabis market driver impact
  • Fig. 14 Washington legal cannabis market restraint impact
  • Fig. 15 Washington legal cannabis market: Source movement analysis
  • Fig. 16 Washington legal cannabis market: Source outlook and key takeaways
  • Fig. 17 Hemp market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Hemp CBD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Industrial hemp market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Flower market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Oil and tinctures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Washington legal cannabis market: Derivatives movement analysis
  • Fig. 24 Washington legal cannabis market: Derivatives outlook and key takeaways
  • Fig. 25 CBD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 THC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Washington legal cannabis market: End-use movement analysis
  • Fig. 29 Washington legal cannabis market: End-use outlook and key takeaways
  • Fig. 30 Industrial use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Medical use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Chronic pain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Depression and anxiety market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Arthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Post-traumatic stress disorder (PTSD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Migraines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Epilepsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Alzheimer's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Multiple sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 AIDS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Amyotrophic lateral sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Tourette's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Parkinson's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Glaucoma market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Recreational Use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key company categorization